Topiramate Extended Release Generic

Quote
anonymous said:
I would like to discuss this enormous elephant in the room. Rockville says don’t worry everything will be fine because

It’s not “AB rated” pharmacy can’t switch to generic

“Generic” has been out for years and won’t effect our business

It will be priced so high, noble

What about the all mighty insurance companies???

Wait until they send out a mass letter to all of your docs saying a real generic extend release is available

Or when they make generic extended release a step through after IR before you can get to TXR

Or what about when the pharmacy calls your doc and says hey I know you just wrote TXR but there’s a PA and we can fill generic XR right now!

How many docs say no send the PA over I think this patients needs the benefits of TXR over generic extended release???
Click to expand...


Its pointless to try and discuss this with them. Our best bet is just to let it play out. Once it becomes available in March Supernus will not be able to lie about the impact it will most certainly have.
 


















anonymous said:
is it true that it will be really hard to sell against the generic? What about coverage ?
Click to expand...

This will be written off as corporate kool aid but there’s a reason we‘be always outperformed qudexy. It wasn’t cost or coverage because, despite what we were told, it has always been easier and cheaper to get qudexy or the AG. It’s because txr actually offers clinical value over IR. Maybe some of us have said it so many times we take it for granted or don’t believe it anymore but the slower rate of rise actually does lessen SEs. And the SEs of tpm are not just annoying, they effect daily function. Less SEs actually does allow patients to get to higher more efficacious doses. This generic still has to be approved by the FDA and it will do so based on showing bioavailability to qudexy/AG, which has the same if not higher rate of rise as IR. It might hurt at first if hcps believe it’s a cheaper/easier option of txr but they will see it’s not when patients call back pissed off that their migraines are back or they can’t remember their own name.
 






anonymous said:
This will be written off as corporate kool aid but there’s a reason we‘be always outperformed qudexy. It wasn’t cost or coverage because, despite what we were told, it has always been easier and cheaper to get qudexy or the AG. It’s because txr actually offers clinical value over IR. Maybe some of us have said it so many times we take it for granted or don’t believe it anymore but the slower rate of rise actually does lessen SEs. And the SEs of tpm are not just annoying, they effect daily function. Less SEs actually does allow patients to get to higher more efficacious doses. This generic still has to be approved by the FDA and it will do so based on showing bioavailability to qudexy/AG, which has the same if not higher rate of rise as IR. It might hurt at first if hcps believe it’s a cheaper/easier option of txr but they will see it’s not when patients call back pissed off that their migraines are back or they can’t remember their own name.
Click to expand...

You are right.....it’s kool aid
 






anonymous said:
This will be written off as corporate kool aid but there’s a reason we‘be always outperformed qudexy. It wasn’t cost or coverage because, despite what we were told, it has always been easier and cheaper to get qudexy or the AG. It’s because txr actually offers clinical value over IR. Maybe some of us have said it so many times we take it for granted or don’t believe it anymore but the slower rate of rise actually does lessen SEs. And the SEs of tpm are not just annoying, they effect daily function. Less SEs actually does allow patients to get to higher more efficacious doses. This generic still has to be approved by the FDA and it will do so based on showing bioavailability to qudexy/AG, which has the same if not higher rate of rise as IR. It might hurt at first if hcps believe it’s a cheaper/easier option of txr but they will see it’s not when patients call back pissed off that their migraines are back or they can’t remember their own name.
Click to expand...

Yes, you are right the generic will not be as good as TXR. It will however be significantly better than IR and significantly cheaper than TXR. That's all that matters!! If you cannot see this for what it is you need help.
 






anonymous said:
Yes, you are right the generic will not be as good as TXR. It will however be significantly better than IR and significantly cheaper than TXR. That's all that matters!! If you cannot see this for what it is you need help.
Click to expand...

Oh also the reason we have always outperformed Qudexy is because our sales reps SIGNIFICANTLY outworked and OUTHUSTLED the reps for Qudexy.
 












anonymous said:
This will be written off as corporate kool aid but there’s a reason we‘be always outperformed qudexy. It wasn’t cost or coverage because, despite what we were told, it has always been easier and cheaper to get qudexy or the AG. It’s because txr actually offers clinical value over IR. Maybe some of us have said it so many times we take it for granted or don’t believe it anymore but the slower rate of rise actually does lessen SEs. And the SEs of tpm are not just annoying, they effect daily function. Less SEs actually does allow patients to get to higher more efficacious doses. This generic still has to be approved by the FDA and it will do so based on showing bioavailability to qudexy/AG, which has the same if not higher rate of rise as IR. It might hurt at first if hcps believe it’s a cheaper/easier option of txr but they will see it’s not when patients call back pissed off that their migraines are back or they can’t remember their own name.
Click to expand...

I hope you are just doing your job and you don’t really believe any of this or you are due for a nervous breakdown come next year. There is zero clinical benefit in Trokendi XR over Qudexy and even if there was we couldn’t prove it because we have no data!!!
 






anonymous said:
I hope you are just doing your job and you don’t really believe any of this or you are due for a nervous breakdown come next year. There is zero clinical benefit in Trokendi XR over Qudexy and even if there was we couldn’t prove it because we have no data!!!
Click to expand...

If you believe that then I understand why you hate this job
 






anonymous said:
If you believe that then I understand why you hate this job
Click to expand...

What it really boils down to is the doctor will have a choice of two medications. Trokendi XR will require a PA and has a copay card that works "sometimes". The generic will not require a PA and will not require a copay card at all. For those of you out there that have TXR Medicaid coverage this will impact you as well. As state Medicaid plans are likely to update their formulary to enforce that patients have to ST the generic before they get TXR. Or even worse, that existing Medicaid patients on TXR have to be switched to the generic and show failure before going back to TXR. There is really nothing left to ponder in this situation.
 


















anonymous said:
That moment when today’s CP makes it into your team’s communication
Click to expand...
CafePharma makes it into all my region’s conversation. Good to hear I’m not alone. The best is when our RD says it, then repeats it on here, pretty much exact, then acts surprised that CP exists. I actually saw our RD on here once while they were in my car. Sure enough, next stop I checked and there was some crazy s*h*i*t posted. LMAO. FTR I think my RD is a pot stirring psycho with nothing else in life to get excited about so stirs crap on here for kicks.
 






























anonymous said:
What a psycho! You act like we working down at the plant on an assembly line. 90% of this job is down time you hobo
Click to expand...
And obviously the best use of that time is trolling CP like an ill equipped sophomore. “Dur team, I don’t have anything to share today because I gave my brain to corporate when I took this job, so let me get ideas from CP. Dur.”
 






anonymous said:
What a psycho! You act like we working down at the plant on an assembly line. 90% of this job is down time you hobo
Click to expand...
Did you use the word psycho because someone else used the word psycho like 3-5 posts ago? Nothing really to add except, that’s such a weird thing on Supernus’s forum that I don’t see on others...one person uses an abnormal word or phrase, then like 5-10 posts later someone on the other side of the argument uses it. You people should try some synonyms, if that’s not too hard
 






Top Bottom
Back
Quote